Point-of-Care Coagulation (POCC) Testing Devices Market Size, Share & Industry Analysis, By Device Type (Anticoagulation Monitoring Devices {Prothrombin Time/International Normalized Ratio (PT/INR) Testing Devices, Activated Clotting Time (ACT), and Activated Partial Thromboplastin Time (aPPT)}, Platelet Function Monitoring Devices, Viscoelastic Coagulation Monitoring Devices {Thromboelastography (TEG) and Rotational Thromboelastometry (ROTEM)}, and Others), By End User (Hospitals & Clinics, Homecare Settings, and Others), and Regional Forecast, 2025-2032

Last Updated: April 07, 2025 | Format: PDF | Report ID: FBI101235

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2024
Estimated Year	2025
Forecast Period	2025-2032
Historical Period	2019-2023
Growth rate	CAGR of 7.5% from 2025-2032
Unit	Value (USD billion)
Segmentation	By Device Type Anticoagulation Monitoring Devices Prothrombin Time/International Normalized Ratio (PT/INR) Testing Devices Activated Clotting Time (ACT) Activated Partial Thromboplastin Time (aPTT) Platelet Function Monitoring Devices Viscoelastic Coagulation Monitoring Devices Thromboelastography (TEG) Rotational Thromboelastometry (ROTEM) Others
	By End User Hospitals & Clinics Homecare Settings Others
	By Region North America (by Device Type, by End User, by Country) U.S. Canada Europe (by Device Type, by End User, by Country/Sub-region) U.K. Germany France Italy Spain Scandinavia Rest of Europe Asia Pacific (by Device Type, by End User, by Country/Sub-region) Japan China India Australia Southeast Asia Rest of the Asia Pacific Latin America (by Device Type, by End User, by Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (by Device Type, by End User, by Country/Sub-region) GCC South Africa Rest of the Middle East & Africa